377 related articles for article (PubMed ID: 17018256)
1. Ovarian cancer.
Colombo N; Van Gorp T; Parma G; Amant F; Gatta G; Sessa C; Vergote I
Crit Rev Oncol Hematol; 2006 Nov; 60(2):159-79. PubMed ID: 17018256
[TBL] [Abstract][Full Text] [Related]
2. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
Orr JW; Orr P; Kern DH
Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
[TBL] [Abstract][Full Text] [Related]
3. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
4. [Ovarian carcinoma: current therapeutic aspects. A review].
Buser K; Hänggi W; Greiner R; Schatzmann E
Schweiz Med Wochenschr; 1990 Nov; 120(44):1617-32. PubMed ID: 2251477
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of epithelial ovarian cancer.
Bhoola S; Hoskins WJ
Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
[TBL] [Abstract][Full Text] [Related]
6. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
7. Update on the management of ovarian cancer.
Ozols RF
Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699
[TBL] [Abstract][Full Text] [Related]
8. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.
Weinberg LE; Rodriguez G; Hurteau JA
J Surg Oncol; 2010 Mar; 101(4):334-43. PubMed ID: 20187069
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of epithelial ovarian cancer.
Memarzadeh S; Berek JS
J Reprod Med; 2001 Jul; 46(7):621-9; discussion 629-30. PubMed ID: 11499181
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of epithelial ovarian cancer].
Langmár Z; Csömör S
Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of ovarian cancer].
Cianti C
Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
[TBL] [Abstract][Full Text] [Related]
12. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
13. Epithelial ovarian cancer: second and third line chemotherapy (review).
Latorre A; De Lena M; Catino A; Crucitta E; Sambiasi D; Guida M; Misino A; Lorusso V
Int J Oncol; 2002 Jul; 21(1):179-86. PubMed ID: 12063566
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the ovary.
Pectasides D; Pectasides E; Kassanos D
Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
Moore KN; Reid MS; Fong DN; Myers TK; Landrum LM; Moxley KM; Walker JL; McMeekin DS; Mannel RS
Gynecol Oncol; 2008 Aug; 110(2):133-9. PubMed ID: 18495221
[TBL] [Abstract][Full Text] [Related]
16. Achievements and unmet needs in the management of advanced ovarian cancer.
Guarneri V; Piacentini F; Barbieri E; Conte PF
Gynecol Oncol; 2010 May; 117(2):152-8. PubMed ID: 20056266
[TBL] [Abstract][Full Text] [Related]
17. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
Zivanovic O; Braun M; Park TW; Kuhn W
Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
[TBL] [Abstract][Full Text] [Related]
18. Management of relapsed/refractory epithelial ovarian cancer: current standards and novel approaches.
Lin H; Changchien CC
Taiwan J Obstet Gynecol; 2007 Dec; 46(4):379-88. PubMed ID: 18182343
[TBL] [Abstract][Full Text] [Related]
19. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
20. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]